Articles published by Vor Biopharma


Vor Bio to Participate in Upcoming Investor Conferences
April 18, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR

Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
March 23, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR

Vor Bio to Participate in Upcoming Investor Conferences
February 21, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR


Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings
January 19, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR



First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
December 07, 2022
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR

Vor Bio to Participate in Upcoming Investor Conferences
November 22, 2022
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR


Vor Bio to Participate in Upcoming Investor Conferences
November 01, 2022
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR

Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer
October 12, 2022
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.